Last 12 months
Inside the activity.
3 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversion2017 Performance Shares · Derivative | 2,063 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005391 · form4.xml · derivative · entry 4 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
TANJI KENNETHEVP and CFO
|
Tax withholdingCommon Stock | 1,553 | $95.87 | $148,886.11 |
DisclosureSEC source: 0001127602-20-005391 · form4.xml · nonDerivative · entry 2 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,218 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:09 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversionCommon Stock | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005391 · form4.xml · nonDerivative · entry 1 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:14 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2020 Performance Share · Derivative | 51,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005397 · form4.xml · derivative · entry 8 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,946 Underlying: Common Stock · 51,946 shares Expires not disclosed F8 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F9 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F9 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:14 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 93,469 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005397 · form4.xml · derivative · entry 7 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,469 Underlying: Common Stock · 93,469 shares Expires 2030-02-11 F7 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:14 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversion2017 Performance Shares · Derivative | 14,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005397 · form4.xml · derivative · entry 6 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:14 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Tax withholdingCommon Stock | 15,476 | $95.87 | $1,483,684.12 |
DisclosureSEC source: 0001127602-20-005397 · form4.xml · nonDerivative · entry 2 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,713 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:14 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversionCommon Stock | 30,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005397 · form4.xml · nonDerivative · entry 1 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: The performance share award includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:07 UTC |
Axel RobertSVP and Controller
|
Exercise / conversion2017 Performance Shares · Derivative | 1,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005388 · form4.xml · derivative · entry 6 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:07 UTC |
Axel RobertSVP and Controller
|
Grant2020 Performance Share · Derivative | 4,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005388 · form4.xml · derivative · entry 5 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 Underlying: Common Stock · 4,381 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:07 UTC |
Axel RobertSVP and Controller
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 3,942 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005388 · form4.xml · derivative · entry 4 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,942 Underlying: Common Stock · 3,942 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:07 UTC |
Axel RobertSVP and Controller
|
Tax withholdingCommon Stock | 1,335 | $95.87 | $127,986.45 |
DisclosureSEC source: 0001127602-20-005388 · form4.xml · nonDerivative · entry 2 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,279 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:07 UTC |
Axel RobertSVP and Controller
|
Exercise / conversionCommon Stock | 3,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005388 · form4.xml · nonDerivative · entry 1 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
Harris Timothy PEVP and General Counsel
|
Grant2020 Performance Share · Derivative | 17,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005386 · form4.xml · derivative · entry 6 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,211 Underlying: Common Stock · 17,211 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
Harris Timothy PEVP and General Counsel
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 15,485 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005386 · form4.xml · derivative · entry 5 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,485 Underlying: Common Stock · 15,485 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
Harris Timothy PEVP and General Counsel
|
Exercise / conversion2017 Performance Shares · Derivative | 7,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005386 · form4.xml · derivative · entry 4 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,113 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
Harris Timothy PEVP and General Counsel
|
Tax withholdingCommon Stock | 6,276 | $95.87 | $601,680.12 |
DisclosureSEC source: 0001127602-20-005386 · form4.xml · nonDerivative · entry 2 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,437 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:06 UTC |
Harris Timothy PEVP and General Counsel
|
Exercise / conversionCommon Stock | 15,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005386 · form4.xml · nonDerivative · entry 1 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:01 UTC |
Sleyster ScottExecutive Vice President
|
Grant2020 Performance Share · Derivative | 23,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005383 · form4.xml · derivative · entry 6 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,783 Underlying: Common Stock · 23,783 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:01 UTC |
Sleyster ScottExecutive Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 42,793 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005383 · form4.xml · derivative · entry 5 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,793 Underlying: Common Stock · 42,793 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:01 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversion2017 Performance Shares · Derivative | 7,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005383 · form4.xml · derivative · entry 4 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,397 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:01 UTC |
Sleyster ScottExecutive Vice President
|
Tax withholdingCommon Stock | 5,557 | $95.87 | $532,749.59 |
DisclosureSEC source: 0001127602-20-005383 · form4.xml · nonDerivative · entry 2 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,267.12 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 01:01 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversionCommon Stock | 14,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005383 · form4.xml · nonDerivative · entry 1 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,824.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Grant2020 Performance Share · Derivative | 3,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · derivative · entry 7 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,443 Underlying: Common Stock · 3,443 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 3,097 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · derivative · entry 6 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 Underlying: Common Stock · 3,097 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Exercise / conversion10/10/2017 Performance Shares · Derivative | 916 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · derivative · entry 5 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Exercise / conversion2017 Performance Shares · Derivative | 427 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · derivative · entry 4 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Tax withholdingCommon Stock | 857 | $95.87 | $82,160.59 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · nonDerivative · entry 2 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,572 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:59 UTC |
Woods CandaceSenior Vice President
|
Exercise / conversionCommon Stock | 2,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005382 · form4.xml · nonDerivative · entry 1 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:58 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2020 Performance Share · Derivative | 16,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005381 · form4.xml · derivative · entry 6 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,898 Underlying: Common Stock · 16,898 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:58 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 15,203 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005381 · form4.xml · derivative · entry 5 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,203 Underlying: Common Stock · 15,203 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:58 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversion2017 Performance Shares · Derivative | 7,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005381 · form4.xml · derivative · entry 4 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,397 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:58 UTC |
Silitch Nicholas CSenior Vice President
|
Tax withholdingCommon Stock | 5,804 | $95.87 | $556,429.48 |
DisclosureSEC source: 0001127602-20-005381 · form4.xml · nonDerivative · entry 2 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,442 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:58 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversionCommon Stock | 13,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005381 · form4.xml · nonDerivative · entry 1 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2020 Performance Share · Derivative | 20,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · derivative · entry 7 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,653 Underlying: Common Stock · 20,653 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 37,163 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · derivative · entry 6 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,163 Underlying: Common Stock · 37,163 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversion10/2/2017 Performance Shares · Derivative | 872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · derivative · entry 5 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversion2017 Performance Shares · Derivative | 1,992 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · derivative · entry 4 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,992 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Tax withholdingCommon Stock | 2,188 | $95.87 | $209,763.56 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · nonDerivative · entry 2 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,557 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:54 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversionCommon Stock | 6,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005380 · form4.xml · nonDerivative · entry 1 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:53 UTC |
Alziari LucienExecutive Vice President
|
Grant2020 Performance Share · Derivative | 14,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005379 · form4.xml · derivative · entry 2 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,082 Underlying: Common Stock · 14,082 shares Expires not disclosed F2 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F3 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F3 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:53 UTC |
Alziari LucienExecutive Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 12,669 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005379 · form4.xml · derivative · entry 1 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,669 Underlying: Common Stock · 12,669 shares Expires 2030-02-11 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:51 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2020 Performance Share · Derivative | 8,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005378 · form4.xml · derivative · entry 6 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,762 Underlying: Common Stock · 8,762 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. F7 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:51 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2020 Employee Stock Option (Right to Buy) · Derivative | 7,883 | $0.00 Strike: $95.87 | $0.00 |
DisclosureSEC source: 0001127602-20-005378 · form4.xml · derivative · entry 5 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,883 Underlying: Common Stock · 7,883 shares Expires 2030-02-11 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 11, 2021. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:51 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversion2017 Performance Shares · Derivative | 1,518 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005378 · form4.xml · derivative · entry 4 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,518 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:51 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Tax withholdingCommon Stock | 587 | $95.87 | $56,275.69 |
DisclosureSEC source: 0001127602-20-005378 · form4.xml · nonDerivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,528 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 00:51 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 1,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005378 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares based upon performance relative to the average Return On Equity (ROE) goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 11, 2020 Filed Feb 19, 2020 22:11 UTC |
Baltimore Thomas J JrDirector
|
PurchaseCommon Stock | 500 | $95.82 | $47,910.00 |
DisclosureSEC source: 0001127602-20-006506 · form4.xml · nonDerivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 20:43 UTC |
KRAPEK KARL JDirector
|
OtherNotional Shares - Optional · Derivative | 3,739 | $95.49 Strike: $0.00 | $357,037.11 |
DisclosureSEC source: 0001127602-20-002248 · form4.xml · derivative · entry 1 KRAPEK KARL J · CIK 0001238288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Common Stock · 3,739 shares Expires not disclosed F1 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
| January 01, 2020 Filed Jan 2, 2020 20:12 UTC |
Baltimore Thomas J JrDirector
|
GrantNotional Shares - Optional · Derivative | 612 | $93.74 Strike: $0.00 | $57,368.88 |
DisclosureSEC source: 0001127602-20-000081 · form4.xml · derivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,959 Underlying: Common Stock · 612 shares Expires not disclosed F1 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.